Acquisition and Long-term Observation of Patients With Severe Allergic Reactions

What this Trial Is About

Researchers are gathering detailed, standardized information about patients who have experienced anaphylactic reactions to better understand the symptoms, triggers, and management of these severe allergic responses. The study aims to improve diagnosis and long-term care for people affected by anaphylaxis by analyzing data collected over time. This research also explores genetic and biomarker factors that may influence the risk and severity of these reactions. Participants who have had an anaphylactic reaction are observed without receiving any specific treatment through the study. Blood sampling is optional but encouraged, as it helps identify sensitization profiles and possible biological mechanisms behind anaphylaxis. The study collects data over a long period, focusing on risk factors, use of adrenaline, country-specific management differences, and genetic and epigenetic markers related to anaphylaxis. Throughout the study, participants provide information and may undergo optional blood tests to help researchers track changes and outcomes related to their allergic reactions. The primary outcome measures include assessing risk factors over 10 years, along with secondary outcomes such as adrenaline use, biomarker validation, and epigenetic studies. This long-term observation helps enhance understanding of anaphylaxis and guides better prevention and treatment strategies for affected individuals.

Acquisition and Long-term Observation of Patients With Severe Allergic Reactions